G1 Therapeutics, Inc.
GTHX
Revenue
16.55M
▲2.07M▲14.30%
3 Months ChangeAssets
98.69M
▼-3.34M▼-3.27%
3 Months ChangeLiabilities
74.10M
▼-190.00k▼-0.2558%
3 Months ChangeFree Cash Flow
-21.76M
▼-3.58M▼-19.70%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-06-24
Form 8-K
ID: 0001628280-24-029426
2024-06-14
Form 8-K
ID: 0001628280-24-028288
2024-05-01
Form 10-Q
ID: 0001628280-24-019622
2024-05-01
Form 8-K
ID: 0001628280-24-019453
2024-03-22
Form 8-K
ID: 0001628280-24-012736
2024-02-28
Form 8-K
ID: 0001628280-24-007378
2024-02-12
Form 8-K
ID: 0001628280-24-004188
2024-01-08
Form 8-K
ID: 0001628280-24-000755
2023-11-01
Form 10-Q
ID: 0001628280-23-035947
2023-11-01
Form 8-K
ID: 0001628280-23-035780